Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
8%
Ph phase_1
1
8%
Ph early_phase_1
1
8%
Ph phase_4
1
8%
Ph not_applicable
6
50%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
1(10.0%)
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
6(60.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(5)
Terminated(1)
Other(5)

Detailed Status

Completed5
unknown5
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (10.0%)
Phase 11 (10.0%)
Phase 21 (10.0%)
Phase 41 (10.0%)
N/A6 (60.0%)

Trials by Status

completed542%
withdrawn18%
unknown542%
not_yet_recruiting18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
12